Information about Alnisaid
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0452.656.042

VAT liability
Yes
Established
09-05-1994
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Alnisaid

2024 2023 2022 2021
Profit/Loss 107,311 -48 % 205,767 50 % 136,877 -1 % 138,310
Equity 1,407,248 -3 % 1,449,936 8 % 1,344,169 7 % 1,257,292
Gross margin 128,180 -50 % 258,643 834 % 27,680 -16 % 33,142

Publications from Alnisaid

Date Publication
11-09-2023 Capital - Shares - Rubric Restructuring (Fusion, Split, Transfer of Assets, etc...) - Financial Year - Resignations - Appointments (NL)
01-06-2023 Resignations - Appointments (NL)
08-05-2023 Rubric Restructuring (Fusion, Split, Transfer of Assets, etc...) (NL)
24-02-2016 Resignations - Appointments (NL)
18-05-2015 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Alnisaid?
The VAT number of Alnisaid is BE 0452.656.042.
Wat is the PEPPOL ID of Alnisaid?
There is no information available about the PEPPOL ID of Alnisaid or the company is not yet registered on the PEPPOL network.
When was Alnisaid founded?
Alnisaid was founded on 09-05-1994.
What is the address of Alnisaid?
The current registered office of Alnisaid is located at Burgemeester Kenisstraat 1, 2910 Essen.
When was the last time Alnisaid filed their annual financial statements?
The most recent financial statements of Alnisaid were filed on 31-07-2025.
How many employees does Alnisaid have?
There are currently no employees working at Alnisaid or no workforce information is available.
What is the annual turnover of Alnisaid?
At the time of its most recent financial statements, Alnisaid did not publish any turnover figures. Alnisaid reported a gross margin of €128,179.59.